Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Azelis Group NVAZLGF 74 EBITDA Margin % is 10.44% as of Jun. 2026, which is 8% above its 10-year median of 9.64. GuruFocus rates AZLGF with a GF Score™ of 74/100 and a GF Value™ of $18.43 (Significantly Undervalued). The stock has 5 warning signs investors should review. Among 1,577 Chemicals companies, Azelis Group NV ranks worse than 50.22% on this metric.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. Azelis Group NV's EBITDA for the
six
months ended in Jun. 2026 was $262 Mil. Azelis Group NV's Revenue for the
six
months ended in Jun. 2026 was $2,509 Mil. Therefore, Azelis Group NV's EBITDA margin for the quarter that ended in Jun. 2026 was 10.44%.
Azelis Group NV (OTCPK:AZLGF) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Azelis Group NV EBITDA Margin % Related Terms
Azelis Group NV EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Azelis Group NV's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
AZLGF vs LIN, SHW, ECL: EBITDA Margin % Comparison
For the Specialty Chemicals subindustry, Azelis Group NV's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Azelis Group NV EBITDA Margin % vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Azelis Group NV's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Azelis Group NV's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Azelis Group NV (AZLGF) has a EBITDA Margin % of 10.44% as of Jun. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Azelis Group NV and its competitors. This is near median its historical median of 9.64. Over the past decade, Azelis Group NV's EBITDA Margin % has ranged from 7.80 to 11.26. According to the industry distribution chart, Azelis Group NV ranks #792 out of 1577 companies in the Chemicals industry, placing it in the top 50.2%.
Is Azelis Group NV's EBITDA Margin % too high?
Azelis Group NV's current EBITDA Margin % of 10.44% is near median its 10-year median of 9.64. Over the past 10 years, this metric has ranged from a low of 7.80 to a high of 11.26. The Chemicals industry median EBITDA Margin % is 9.67. Azelis Group NV's value of 10.44% is 8% above this industry median. Based on the distribution chart, Azelis Group NV ranks #792 out of 1577 companies in the Chemicals industry, which is below the industry midpoint. Overall, Azelis Group NV has a GF Score™ of 74/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Azelis Group NV's EBITDA Margin % compare to LIN and SHW?
According to the Chemicals industry distribution chart, Azelis Group NV ranks #792 out of 1577 companies for EBITDA Margin %. This places Azelis Group NV in the lower half of its industry. The industry median EBITDA Margin % is 9.67. Azelis Group NV's value of 10.44% is 8% above this benchmark. Historically, Azelis Group NV's own EBITDA Margin % has ranged from 7.80 to 11.26 over the past decade. While the company's 10-year median is 9.64 vs. the industry median of 9.67, Azelis Group NV has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Chemicals company?
The median EBITDA Margin % among Chemicals companies is 9.67, based on 1,577 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Azelis Group NV's current EBITDA Margin % of 10.44% is 8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Azelis Group NV and its competitors. For the Chemicals industry, the median EBITDA Margin % is 9.67 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Azelis Group NV's current EBITDA Margin % is 10.44%, which is near median its own 10-year median of 9.64. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Azelis Group NV stock overvalued right now?
Based on GuruFocus' analysis, Azelis Group NV (AZLGF) is currently considered Significantly Undervalued. The stock's GF Value™ is $18.43, compared to a current price of $11.32 — trading 38.6% below its estimated fair value. The current EBITDA Margin % is 10.44%, which is near median its 10-year median of 9.64 and 8% above the Chemicals industry median of 9.67. Azelis Group NV's overall GF Score™ is 74/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Azelis Group NV (AZLGF), the current EBITDA Margin % is 10.44% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Azelis Group NV (AZLGF) Overvalued in 2026?
Based on GuruFocus' analysis, Azelis Group NV stock appears to be undervalued.
The current stock price of $11.32 is trading 38.6% below its estimated GF Value™ of $18.43.
GuruFocus considers Azelis Group NV to be Significantly Undervalued.
Key valuation signals for AZLGF:
EBITDA Margin %: 10.44% (near median its 10-year median of 9.64)
GF Value™: $18.43 vs. price of $11.32 (38.6% below fair value)
Industry Position: 8% above the Chemicals median (#792 of 1577)
No single metric tells the full story. See the AZLGF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Azelis Group NV is an innovation service provider and distributor of speciality chemicals and food ingredients. The Group provides innovation services, multi-product formulations, technical and regulatory expertise, co-creation support, digital solutions, and supply chain services. It serves Food & Nutrition, Animal Nutrition, Personal Care, Home Care & Industrial Cleaning, Pharmaceuticals & Healthcare, Agriculture & Environmental Solutions, Flavours & Fragrances, and Nutraceuticals. The Group operates through four segments: EMEA, Americas, Asia Pacific, and Group holding & other, covering operating companies across Europe, the Middle East and Africa, the United States, Canada, Mexico and South America, Asia, and the Pacific region.
74GF Score
Get the complete analysis for AZLGF
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
AZLGF has been successfully added to your 
